Dose modifications and dose intensity during treatment with pirfenidone
Steven Nathan, Lisa Lancaster, Carlo Albera, Marilyn Glassberg, Jeffrey Swigris, Frank Gilberg, Klaus-Uwe Kirchgaessler, Ute Petzinger, Paul Noble
European Respiratory Journal 2016 48: OA1764; DOI: 10.1183/13993003.congress-2016.OA1764
Steven Nathan
1Lung Transplant Program, Inova Fairfax Hospital, Falls Church, VAUnited States
Lisa Lancaster
2Department of Medicine, Vanderbilt University Medical Center, Nashville, TNUnited States
Carlo Albera
3Department of Clinical and Biological Sciences, University of Turin, Turin, Italy
Marilyn Glassberg
4Department of Medicine and Surgery, University of Miami School of Medicine, Miami, FLUnited States
Jeffrey Swigris
5Department of Medicine, National Jewish Health, Denver, COUnited States
Frank Gilberg
6Medical Affairs, Roche, Basel, Switzerland
Klaus-Uwe Kirchgaessler
6Medical Affairs, Roche, Basel, Switzerland
Ute Petzinger
7Clinical Research, Accovion GmbH, Eschborn, Germany
Paul Noble
8Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, CAUnited States
Vol 48 Issue suppl 60
Table of Contents
Dose modifications and dose intensity during treatment with pirfenidone
Steven Nathan, Lisa Lancaster, Carlo Albera, Marilyn Glassberg, Jeffrey Swigris, Frank Gilberg, Klaus-Uwe Kirchgaessler, Ute Petzinger, Paul Noble
European Respiratory Journal Sep 2016, 48 (suppl 60) OA1764; DOI: 10.1183/13993003.congress-2016.OA1764
Dose modifications and dose intensity during treatment with pirfenidone
Steven Nathan, Lisa Lancaster, Carlo Albera, Marilyn Glassberg, Jeffrey Swigris, Frank Gilberg, Klaus-Uwe Kirchgaessler, Ute Petzinger, Paul Noble
European Respiratory Journal Sep 2016, 48 (suppl 60) OA1764; DOI: 10.1183/13993003.congress-2016.OA1764